Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 97

Results For "IND"

5906 News Found

India approves LumiraDX’s Antigen test kit
Medical Device | October 21, 2021

India approves LumiraDX’s Antigen test kit

The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19


AstraZeneca India opens clinical data and insights division
News | October 20, 2021

AstraZeneca India opens clinical data and insights division

The division is expected to grow to over a 100-member strong team by 2022


Trivitron partners with Diagon-Vanguard to launch its coagulation range in India
Medical Device | October 20, 2021

Trivitron partners with Diagon-Vanguard to launch its coagulation range in India

The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary


Alcon announces launch of AcrySof IQ Vivity in India,
Medical Device | October 19, 2021

Alcon announces launch of AcrySof IQ Vivity in India,

It is the first presbyopia-correcting lens implant for cataract surgery


Astra’s antibody injection trial indicates it can prevent and treat Covid-19
Biotech | October 11, 2021

Astra’s antibody injection trial indicates it can prevent and treat Covid-19

AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial


AstraZeneca India launches solar project to achieve sustainability goals
Sustainability | October 11, 2021

AstraZeneca India launches solar project to achieve sustainability goals

The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality


Thermo Fisher Scientific introduces On the Go mobile app in India
Digitisation | October 07, 2021

Thermo Fisher Scientific introduces On the Go mobile app in India

The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries


Lilly to transfer rights of two diabetes drugs to Cipla in India
Drug Approval | October 04, 2021

Lilly to transfer rights of two diabetes drugs to Cipla in India

Lilly will continue to maintain its existing operating model for the remaining portfolio of products


Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA
Biotech | October 01, 2021

Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA

The company plans to submit the IND application by the end of 2021


Aurobindo Pharma’s subsidiary opens logistics centre in France
Supply Chain | September 30, 2021

Aurobindo Pharma’s subsidiary opens logistics centre in France

The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon